Predictive biomarkers for anthacycline benefit in
early breast cancer
Joseph Ragaz, MD, FRCPC

Measuring the quality of care provided to patients
with colorectal cancer
Robin Urquhart, MSc and Eva Grunfeld, MD, DPhil, FCFP

Reports from MASCC and ASCO

SUPPORTIVE CARE: symptom patterns in patients
with advanced cancer
Maragret Fitch, MScN, PhD and Barry D. Bultz, PhD, RPsych

COLON CANCER: biochemical markers
Hagen Kennecke, MD, FRCPC

BREAST CANCER: nab-paclitaxel in metastatic disease
Susan Dent, MD, BSc, FRCPC

RENAL CANCER: advanced disease
Bernhard Eigl, MD, FRCPC

Innovations in assessment and management
of breakthrough cancer pain
Challenges and successes
Neil A. Hagen, MD, FRCPC

MEDICAL MEETINGS ROSTER

DRUG & THERAPEUTIC UPDATES